Literature DB >> 26292296

M-Protein Analysis of Streptococcus pyogenes Isolates Associated with Acute Rheumatic Fever in New Zealand.

Deborah A Williamson1, Pierre R Smeesters2, Andrew C Steer2, John D Steemson3, Adrian C H Ng3, Thomas Proft4, John D Fraser4, Michael G Baker5, Julie Morgan6, Philip E Carter6, Nicole J Moreland7.   

Abstract

We applied an emm cluster typing system to group A Streptococcus strains in New Zealand, including those associated with acute rheumatic fever (ARF). We observed few so-called rheumatogenic emm types but found a high proportion of emm types previously associated with pyoderma, further suggesting a role for skin infection in ARF.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26292296      PMCID： PMC4609735          DOI： 10.1128/JCM.02129-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci.

Authors:  B Beall; R Facklam; T Thompson
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

2.  Rheumatogenic and nephritogenic streptococci.

Authors:  G H Stollerman
Journal:  Circulation       Date:  1971-06       Impact factor: 29.690

3.  New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.

Authors:  James B Dale; Thomas A Penfound; Edna Y Chiang; William J Walton
Journal:  Vaccine       Date:  2011-09-13       Impact factor: 3.641

Review 4.  Streptococcal skin infection and rheumatic heart disease.

Authors:  Tom Parks; Pierre R Smeesters; Andrew C Steer
Journal:  Curr Opin Infect Dis       Date:  2012-04       Impact factor: 4.915

5.  Potential coverage of a multivalent M protein-based group A streptococcal vaccine.

Authors:  James B Dale; Thomas A Penfound; Boubou Tamboura; Samba O Sow; James P Nataro; Milagritos Tapia; Karen L Kotloff
Journal:  Vaccine       Date:  2013-01-31       Impact factor: 3.641

6.  Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States.

Authors:  Guliz Erdem; Carla Mizumoto; David Esaki; Venu Reddy; David Kurahara; Karen Yamaga; Lucienne Abe; Dwight Johnson; Kara Yamamoto; Edward L Kaplan
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

7.  Epidemiology of acute rheumatic fever in New Zealand 1996-2005.

Authors:  Richard Jaine; Michael Baker; Kamalesh Venugopal
Journal:  J Paediatr Child Health       Date:  2008-10       Impact factor: 1.954

Review 8.  Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline.

Authors:  Polly Atatoa-Carr; Diana Lennon; Nigel Wilson
Journal:  N Z Med J       Date:  2008-04-04

9.  Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates.

Authors:  Silvana Reissmann; Christine M Gillen; Marcus Fulde; René Bergmann; Andreas Nerlich; Reena Rajkumari; Kootallur N Brahmadathan; Gursharan S Chhatwal; D Patric Nitsche-Schmitz
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

10.  Crucial role of the CB3-region of collagen IV in PARF-induced acute rheumatic fever.

Authors:  Katrin Dinkla; Susanne R Talay; Matthias Mörgelin; Rikki M A Graham; Manfred Rohde; D Patric Nitsche-Schmitz; Gursharan S Chhatwal
Journal:  PLoS One       Date:  2009-03-02       Impact factor: 3.240
View more
  19 in total

Review 1.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 2.  Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains?

Authors:  Debra E Bessen
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

3.  Case Report: Concurrent Rheumatic Fever and Acute Post-Streptococcal Glomerulonephritis in a High-Burden Setting.

Authors:  Anna V Nakauyaca; Anna P Ralph; William S Majoni; Nadarajah Kangaharan
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

Review 4.  Acute Rheumatic Fever and Rheumatic Heart Disease: Highlighting the Role of Group A Streptococcus in the Global Burden of Cardiovascular Disease.

Authors:  Tangeni Auala; Ben'Lauro Goncalves Zavale; Amam Çhinyere Mbakwem; Ana Olga Mocumbi
Journal:  Pathogens       Date:  2022-04-21

5.  Canada-Wide Epidemic of emm74 Group A Streptococcus Invasive Disease.

Authors:  Sarah Teatero; Allison McGeer; Gregory J Tyrrell; Linda Hoang; Hanan Smadi; Marc-Christian Domingo; Paul N Levett; Michael Finkelstein; Ken Dewar; Agron Plevneshi; Taryn B T Athey; Jonathan B Gubbay; Michael R Mulvey; Irene Martin; Walter Demczuk; Nahuel Fittipaldi
Journal:  Open Forum Infect Dis       Date:  2018-04-20       Impact factor: 3.835

6.  Estimating the likely true changes in rheumatic fever incidence using two data sources.

Authors:  J Oliver; N Pierse; D A Williamson; M G Baker
Journal:  Epidemiol Infect       Date:  2017-12-06       Impact factor: 4.434

7.  Serological Evidence of Immune Priming by Group A Streptococci in Patients with Acute Rheumatic Fever.

Authors:  Jeremy M Raynes; Hannah R C Frost; Deborah A Williamson; Paul G Young; Edward N Baker; John D Steemson; Jacelyn M Loh; Thomas Proft; P R Dunbar; Polly E Atatoa Carr; Anita Bell; Nicole J Moreland
Journal:  Front Microbiol       Date:  2016-07-22       Impact factor: 5.640

8.  Differences in SpeB protease activity among group A streptococci associated with superficial, invasive, and autoimmune disease.

Authors:  Anhphan T Ly; John P Noto; Odaelys L Walwyn; Robert R Tanz; Stanford T Shulman; William Kabat; Debra E Bessen
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

9.  Antibody responses to collagen peptides and streptococcal collagen-like 1 proteins in acute rheumatic fever patients.

Authors:  Devaki H Pilapitiya; Paul W R Harris; Paulina Hanson-Manful; Reuben McGregor; Renata Kowalczyk; Jeremy M Raynes; Lauren H Carlton; Renwick C J Dobson; Michael G Baker; Margaret Brimble; Slawomir Lukomski; Nicole J Moreland
Journal:  Pathog Dis       Date:  2021-07-09       Impact factor: 3.166

10.  Estimating the risk of acute rheumatic fever in New Zealand by age, ethnicity and deprivation.

Authors:  J K Gurney; J Stanley; M G Baker; N J Wilson; D Sarfati
Journal:  Epidemiol Infect       Date:  2016-06-17       Impact factor: 4.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.